Does NEMOLIZUMAB-ILTO Cause Incorrect dose administered? 579 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 579 reports of Incorrect dose administered have been filed in association with NEMOLIZUMAB-ILTO. This represents 13.8% of all adverse event reports for NEMOLIZUMAB-ILTO.
579
Reports of Incorrect dose administered with NEMOLIZUMAB-ILTO
13.8%
of all NEMOLIZUMAB-ILTO reports
0
Deaths
1
Hospitalizations
How Dangerous Is Incorrect dose administered From NEMOLIZUMAB-ILTO?
Of the 579 reports, 1 (0.2%) required hospitalization.
Is Incorrect dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEMOLIZUMAB-ILTO. However, 579 reports have been filed with the FAERS database.
What Other Side Effects Does NEMOLIZUMAB-ILTO Cause?
Inappropriate schedule of product administration (826)
Product dose omission issue (792)
Device malfunction (761)
Pruritus (416)
Rash (263)
Headache (181)
Drug ineffective (158)
Device leakage (153)
Device use issue (120)
Dermatitis atopic (117)
What Other Drugs Cause Incorrect dose administered?
TIRZEPATIDE (23,301)
ADALIMUMAB (14,000)
DUPILUMAB (9,907)
RANITIDINE (9,337)
INSULIN LISPRO (8,318)
ACETAMINOPHEN (5,316)
DULAGLUTIDE (5,207)
SECUKINUMAB (4,524)
INSULIN GLARGINE (3,070)
SOMATROPIN (2,772)
Which NEMOLIZUMAB-ILTO Alternatives Have Lower Incorrect dose administered Risk?
NEMOLIZUMAB-ILTO vs NEOMYCIN
NEMOLIZUMAB-ILTO vs NEORAL
NEMOLIZUMAB-ILTO vs NEOSTIGMINE
NEMOLIZUMAB-ILTO vs NEOSTIGMINE METHYLSULFATE
NEMOLIZUMAB-ILTO vs NEPAFENAC